« Strained Silicon | Main | LegalForce IP »
March 6, 2007
Bloodless
Roche
sued Apex Biotechnology and Hypoguard, then Home Diagnostics, over its diabetes
test devices, patented under
5,366,609 &
RE 36,268. Apex and Hypoguard filed summary judgment motions, mooted by
subsequent settlement under confidential terms. Last Friday, Home Diagnostics
won a summary judgment of non-infringement.
Roche said it had spent millions since 1987 developing its patented "biosensing" blood glucose monitors. But Home Diagnostics argued that it didn't meet three claimed limitations, to which the judge agreed. J. Richard Damron, CEO of Home Diagnostics, crowed, "The court's rulings validate our longstanding position that the lawsuit was without merit."
Posted by Patent Hawk at March 6, 2007 10:19 PM | Litigation